LT4251B - Carbamazepine medicament with retarded active substance release - Google Patents
Carbamazepine medicament with retarded active substance release Download PDFInfo
- Publication number
- LT4251B LT4251B LT97-012A LT97012A LT4251B LT 4251 B LT4251 B LT 4251B LT 97012 A LT97012 A LT 97012A LT 4251 B LT4251 B LT 4251B
- Authority
- LT
- Lithuania
- Prior art keywords
- carbamazepine
- film
- ratio
- forming agent
- process according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19944423078 DE4423078B4 (de) | 1994-07-01 | 1994-07-01 | Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung |
Publications (2)
Publication Number | Publication Date |
---|---|
LT97012A LT97012A (en) | 1997-08-25 |
LT4251B true LT4251B (en) | 1997-12-29 |
Family
ID=6522000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT97-012A LT4251B (en) | 1994-07-01 | 1997-01-30 | Carbamazepine medicament with retarded active substance release |
Country Status (23)
Country | Link |
---|---|
US (1) | US5888545A (hu) |
EP (1) | EP0768882B1 (hu) |
JP (1) | JPH10502358A (hu) |
KR (1) | KR100344477B1 (hu) |
CN (1) | CN1101191C (hu) |
AT (1) | ATE169818T1 (hu) |
BG (1) | BG62794B1 (hu) |
BR (1) | BR9508202A (hu) |
CA (1) | CA2194216A1 (hu) |
CZ (1) | CZ288028B6 (hu) |
DE (2) | DE4423078B4 (hu) |
DK (1) | DK0768882T3 (hu) |
EE (1) | EE03954B1 (hu) |
ES (1) | ES2122630T3 (hu) |
GE (1) | GEP19991819B (hu) |
HU (1) | HU221486B (hu) |
LT (1) | LT4251B (hu) |
LV (1) | LV11820B (hu) |
PL (1) | PL180979B1 (hu) |
RU (1) | RU2141825C1 (hu) |
SK (1) | SK282303B6 (hu) |
UA (1) | UA32598C2 (hu) |
WO (1) | WO1996001112A1 (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6162466A (en) * | 1999-04-15 | 2000-12-19 | Taro Pharmaceutical Industries Ltd. | Sustained release formulation of carbamazepine |
JP2008539240A (ja) * | 2005-04-25 | 2008-11-13 | テバ ファーマシュ−ティカルズ ユーエスエー, インコーポレイテッド | 持続放出性処方物 |
ES2389666T3 (es) * | 2005-09-09 | 2012-10-30 | Angelini Labopharm, Llc | Composición de trazodona para una administración de una vez al día |
US20070160960A1 (en) * | 2005-10-21 | 2007-07-12 | Laser Shot, Inc. | System and method for calculating a projectile impact coordinates |
FR2940910A1 (fr) * | 2009-01-09 | 2010-07-16 | Vetoquinol Sa | Nouveau comprime a base de s-adenosyl-methionine |
CN105997916A (zh) * | 2016-07-19 | 2016-10-12 | 南京正宽医药科技有限公司 | 一种卡马西平片及其制备方法 |
CN108125922A (zh) * | 2018-01-14 | 2018-06-08 | 上海安必生制药技术有限公司 | 一种卡马西平口服缓释制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3725824A1 (de) | 1986-08-07 | 1988-02-11 | Ciba Geigy Ag | Orales therapeutisches system mit systemischer wirkung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
IL86211A (en) * | 1987-05-04 | 1992-03-29 | Ciba Geigy Ag | Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation |
US5326572A (en) * | 1989-03-23 | 1994-07-05 | Fmc Corporation | Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions |
-
1994
- 1994-07-01 DE DE19944423078 patent/DE4423078B4/de not_active Expired - Fee Related
-
1995
- 1995-06-22 US US08/776,266 patent/US5888545A/en not_active Expired - Lifetime
- 1995-06-22 JP JP8503611A patent/JPH10502358A/ja not_active Ceased
- 1995-06-22 HU HU9603565A patent/HU221486B/hu unknown
- 1995-06-22 AT AT95922407T patent/ATE169818T1/de active
- 1995-06-22 SK SK1646-96A patent/SK282303B6/sk not_active IP Right Cessation
- 1995-06-22 UA UA97010403A patent/UA32598C2/uk unknown
- 1995-06-22 ES ES95922407T patent/ES2122630T3/es not_active Expired - Lifetime
- 1995-06-22 RU RU97101469A patent/RU2141825C1/ru active
- 1995-06-22 DK DK95922407T patent/DK0768882T3/da active
- 1995-06-22 WO PCT/DE1995/000805 patent/WO1996001112A1/de active IP Right Grant
- 1995-06-22 CN CN95193915A patent/CN1101191C/zh not_active Expired - Fee Related
- 1995-06-22 CA CA002194216A patent/CA2194216A1/en not_active Abandoned
- 1995-06-22 DE DE59503283T patent/DE59503283D1/de not_active Expired - Lifetime
- 1995-06-22 GE GEAP19953512A patent/GEP19991819B/en unknown
- 1995-06-22 BR BR9508202A patent/BR9508202A/pt not_active Application Discontinuation
- 1995-06-22 PL PL95317996A patent/PL180979B1/pl unknown
- 1995-06-22 KR KR1019960707549A patent/KR100344477B1/ko not_active IP Right Cessation
- 1995-06-22 EP EP95922407A patent/EP0768882B1/de not_active Expired - Lifetime
- 1995-06-22 EE EE9600202A patent/EE03954B1/xx unknown
- 1995-06-22 CZ CZ19963826A patent/CZ288028B6/cs not_active IP Right Cessation
-
1996
- 1996-12-28 BG BG101080A patent/BG62794B1/bg unknown
-
1997
- 1997-01-30 LV LVP-97-13A patent/LV11820B/lv unknown
- 1997-01-30 LT LT97-012A patent/LT4251B/lt not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3725824A1 (de) | 1986-08-07 | 1988-02-11 | Ciba Geigy Ag | Orales therapeutisches system mit systemischer wirkung |
Non-Patent Citations (1)
Title |
---|
K. LEHMANN ET AL.: "Fast-disintegrating tablets with controlled active substance release", PHARM. IND., 1993, pages 940 - 947 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pignatello, Davide Amico, Santina Chiechio, Concetta Spadaro, Giovanni Puglisi, Paolo Giunchedi | Preparation and analgesic activity of eudragit RS100® microparticles containing diflunisal | |
KR930003114B1 (ko) | 2상성의 방출 단면을 가진 제어 방출되는 경구용 제제의 제조방법 | |
AU2001255509B2 (en) | Taste masking coating composition | |
JP2823605B2 (ja) | 安定な遅延医薬剤型 | |
JPH05500674A (ja) | 医薬製剤 | |
PL192961B1 (pl) | Sposób wytwarzania doustnej kompozycji farmaceutycznej i doustna kompozycja farmaceutyczna | |
JPS6229514A (ja) | 医薬活性物質の遅延放出形粒状物及びその製造方法 | |
IL110376A (en) | Pharmaceutical preparations containing iftroban and methods for their preparation | |
AU765765B2 (en) | Particles coated with granulated crystalline ibuprofen | |
MXPA06004700A (es) | Formulacion conteniendo agente farmaceutico comprendiendo un recubrimiento. | |
JPH0632739A (ja) | 胆汁酸の小ペレットを含有する徐放性経口薬剤組成物 | |
JPS6132289B2 (hu) | ||
LT4251B (en) | Carbamazepine medicament with retarded active substance release | |
JPH0157090B2 (hu) | ||
WO1995025516A1 (en) | Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant | |
US20020076444A1 (en) | Novel method for obtaining microspheres and resulting products | |
JPH0776517A (ja) | 医薬用組成物 | |
Jelvehgari et al. | Effects of process variables on micromeritic properties and drug release of non-degradable microparticles | |
JP2002370968A (ja) | 薬物含有徐放性顆粒およびそれを含む錠剤 | |
UA127768C2 (uk) | Спосіб отримання багатоелементної пероральної дозованої лікарської форми з модифікованим вивільненням сукцинату доксиламіну і гідрохлориду піридоксину | |
JPS6141325B2 (hu) | ||
Deasy et al. | Correlation of surface characteristics with ease of production and in vitro release of sodium salicylate from various enteric coated microcapsules prepared by pan coating | |
JP2001151671A (ja) | 突起付き粒子製剤 | |
TR2022002174A2 (tr) | Tolvaptan i̇çeren kati bi̇r farmasöti̇k kompozi̇syon | |
BG64499B1 (bg) | Фармацевтичен адхезивен състав за стомаха и/или дуоденума |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC9A | Transfer of patents |
Free format text: 20021007 * AWD PHARMA GMBH&CO.KG,DE |
|
PD9A | Change of patent owner |
Owner name: AWD. PHARMA GMBH & CO. KG, DE Effective date: 20030113 |
|
MK9A | Expiry of a patent |
Effective date: 20150622 |